KENYON LAWRENCE A 4
4 · Outlook Therapeutics, Inc. · Filed Sep 13, 2019
Insider Transaction Report
Form 4
KENYON LAWRENCE A
CFO and Secretary
Transactions
- Award
Stock Option (Right to Buy)
2019-09-12+450,000→ 450,000 totalExercise: $1.75Exp: 2029-09-12→ Common Stock (450,000 underlying)
Footnotes (1)
- [F1]The shares underlying the option shall vest in four equal annual installments beginning on September 12, 2020 such that the option shall be vested in full on September 12, 2023, subject to the Reporting Person providing continuous service to the Issuer on each such date. Vesting may be accelerated in the event of a change in control as defined in the Issuer's 2015 Equity Incentive Plan, subject to the Reporting Person providing continuous service to the Issuer through such event.